Cargando…
The anticancer phytochemical rocaglamide inhibits Rho GTPase activity and cancer cell migration
Chemotherapy is one of the pillars of anti-cancer therapy. Although chemotherapeutics cause regression of the primary tumor, many chemotherapeutics are often shown to induce or accelerate metastasis formation. Moreover, metastatic tumors are largely resistant against chemotherapy. As more than 90% o...
Autores principales: | Becker, Michael S., Müller, Paul M., Bajorat, Jörg, Schroeder, Anne, Giaisi, Marco, Amin, Ehsan, Ahmadian, Mohammad R., Rocks, Oliver, Köhler, Rebecca, Krammer, Peter H., Li-Weber, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239523/ https://www.ncbi.nlm.nih.gov/pubmed/27340868 http://dx.doi.org/10.18632/oncotarget.10188 |
Ejemplares similares
-
Selectivity Determinants of RHO GTPase Binding to IQGAPs
por: Mosaddeghzadeh, Niloufar, et al.
Publicado: (2021) -
Progress in the Total Synthesis of Rocaglamide
por: Cai, Xiao-hua, et al.
Publicado: (2011) -
RHO GTPase-Related Long Noncoding RNAs in Human Cancers
por: Saliani, Mahsa, et al.
Publicado: (2021) -
The RHO Family GTPases: Mechanisms of Regulation and Signaling
por: Mosaddeghzadeh, Niloufar, et al.
Publicado: (2021) -
Rho GTPases: Masters of cell migration
por: Sadok, Amine, et al.
Publicado: (2014)